Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PROCTER & GAMBLE HEALTH UNICHEM LAB/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 236.1 34.5 684.8% View Chart
P/BV x 1.4 10.5 13.5% View Chart
Dividend Yield % 0.0 2.0 -  

Financials

 UNICHEM LAB   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
UNICHEM LAB/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs4675,366 8.7%   
Low Rs2263,883 5.8%   
Sales per share (Unadj.) Rs190.7740.7 25.8%  
Earnings per share (Unadj.) Rs-28.7138.2 -20.8%  
Cash flow per share (Unadj.) Rs-12.6155.2 -8.1%  
Dividends per share (Unadj.) Rs095.00 0.0%  
Avg Dividend yield %02.1 0.0%  
Book value per share (Unadj.) Rs344.2447.6 76.9%  
Shares outstanding (eoy) m70.4116.60 424.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.86.2 29.1%   
Avg P/E ratio x-12.133.5 -36.1%  
P/CF ratio (eoy) x-27.529.8 -92.2%  
Price / Book Value ratio x1.010.3 9.7%  
Dividend payout %068.7 -0.0%   
Avg Mkt Cap Rs m24,39676,761 31.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,5642,062 172.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,43012,296 109.2%  
Other income Rs m385184 209.4%   
Total revenues Rs m13,81512,480 110.7%   
Gross profit Rs m-8413,247 -25.9%  
Depreciation Rs m1,134281 403.7%   
Interest Rs m1738 2,248.4%   
Profit before tax Rs m-1,7643,142 -56.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m259847 30.5%   
Profit after tax Rs m-2,0222,295 -88.1%  
Gross profit margin %-6.326.4 -23.7%  
Effective tax rate %-14.727.0 -54.4%   
Net profit margin %-15.118.7 -80.7%  
BALANCE SHEET DATA
Current assets Rs m15,88511,713 135.6%   
Current liabilities Rs m6,3966,791 94.2%   
Net working cap to sales %70.740.0 176.5%  
Current ratio x2.51.7 144.0%  
Inventory Days Days51263 19.5%  
Debtors Days Days1,600343 465.8%  
Net fixed assets Rs m15,91110,617 149.9%   
Share capital Rs m141166 84.8%   
"Free" reserves Rs m24,0927,265 331.6%   
Net worth Rs m24,2337,431 326.1%   
Long term debt Rs m6360-   
Total assets Rs m31,82922,330 142.5%  
Interest coverage x-9.2409.1 -2.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.6 76.6%   
Return on assets %-5.810.3 -56.3%  
Return on equity %-8.330.9 -27.0%  
Return on capital %-6.442.4 -15.1%  
Exports to sales %69.70-   
Imports to sales %12.413.1 95.2%   
Exports (fob) Rs m9,366NA-   
Imports (cif) Rs m1,6691,605 103.9%   
Fx inflow Rs m9,3661,465 639.2%   
Fx outflow Rs m1,6691,605 103.9%   
Net fx Rs m7,697-140 -5,490.2%   
CASH FLOW
From Operations Rs m-8512,360 -36.1%  
From Investments Rs m2,028-215 -943.3%  
From Financial Activity Rs m-813-985 82.6%  
Net Cashflow Rs m7461,160 64.3%  

Share Holding

Indian Promoters % 70.2 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 11.3 20.3 55.8%  
FIIs % 0.8 7.6 11.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.8 48.2 61.8%  
Shareholders   20,877 56,730 36.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Unichem Lab vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Unichem Lab vs Procter & Gamble Health Share Price Performance

Period Unichem Lab Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 1.90% -0.55% 1.18%
1-Month -5.40% -7.47% -0.75%
1-Year 78.12% -3.02% 61.82%
3-Year CAGR 16.06% -9.12% 18.16%
5-Year CAGR 19.87% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the Unichem Lab share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Unichem Lab hold a 70.2% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Unichem Lab and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Unichem Lab paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Unichem Lab, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.